Stocks and Investing Stocks and Investing
Mon, July 31, 2017
Fri, July 28, 2017
Thu, July 27, 2017
Wed, July 26, 2017
Tue, July 25, 2017
Mon, July 24, 2017
Fri, July 21, 2017
Thu, July 20, 2017

Matthew Harrison Maintained (SRPT) at Hold with Increased Target to $33 on, Jul 20th, 2017


Published on 2024-10-25 21:46:06 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Hold with Increased Target from $31 to $33 on, Jul 20th, 2017.

Matthew has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Mike Guo of "SunTrust Robinson Humphrey" Upgraded from Hold to Strong Buy on, Wednesday, April 5th, 2017